Skip to main navigation Skip to search Skip to main content

Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group

  • Isabelle Thibault
  • , Eric L. Chang
  • , Jason Sheehan
  • , Manmeet S. Ahluwalia
  • , Matthias Guckenberger
  • , Moon Jun Sohn
  • , Samuel Ryu
  • , Matthew Foote
  • , Simon S. Lo
  • , Alexander Muacevic
  • , Scott G. Soltys
  • , Samuel Chao
  • , Peter Gerszten
  • , Eric Lis
  • , Eugene Yu
  • , Mark Bilsky
  • , Charles Fisher
  • , David Schiff
  • , Michael G. Fehlings
  • , Lijun Ma
  • Susan Chang, Edward Chow, Wendy R. Parelukar, Michael A. Vogelbaum, Arjun Sahgal
  • Centre Hospitalier Universitaire de Quebec
  • University of Southern California
  • University of Virginia
  • Cleveland Clinic Foundation
  • University of Zurich
  • University of Würzburg
  • Inje University
  • Princess Alexandra Hospital
  • Case Western Reserve University
  • Ludwig Maximilian University of Munich
  • Stanford University
  • University of Pittsburgh
  • Memorial Sloan-Kettering Cancer Center
  • Centre of Excellence on Aging and Chronic Diseases of McGill Integrated University Health Network
  • University of British Columbia
  • University Health Network - Toronto Western Hospital
  • University of California at San Francisco
  • University of Toronto
  • Queen's University Kingston

Research output: Contribution to journalReview articlepeer-review

235 Scopus citations

Abstract

The SPine response assessment In Neuro-Oncology (SPINO) group is a committee of the Response Assessment in Neuro-Oncology working group and comprises a panel of international experts in spine stereotactic body radiotherapy (SBRT). Here, we present the group's first report on the challenges in standardising imaging-based assessment of local control and pain for spinal metastases. We review current imaging modalities used in SBRT treatment planning and tumour assessment and review the criteria for pain and local control in registered clinical trials specific to spine SBRT. We summarise the results of an international survey of the panel to establish the range of current practices in assessing tumour response to spine SBRT. The ultimate goal of the SPINO group is to report consensus criteria for tumour imaging, clinical assessment, and symptom-based response criteria to help standardise future clinical trials.

Original languageEnglish
Pages (from-to)e595-e603
JournalThe Lancet Oncology
Volume16
Issue number16
DOIs
StatePublished - 2015

Fingerprint

Dive into the research topics of 'Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group'. Together they form a unique fingerprint.

Cite this